Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 11 of 15
Synendos Therapeuthics
HTGF III
SwitzerlandSector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2020
Hold
6yr
T-Cypher Bio
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2021
Hold
5yr
Tagworks Pharmaceuticals
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2023
Hold
3yr
Telomere Therapeutics
Invivo Ventures
SpainSector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
Theolytics
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2017
Hold
9yr
Thermosome
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2015
Hold
11yr
Thermosome GmbH
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2016
Hold
10yr
Tizona Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2016
Hold
10yr
TolerogenixX
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
TQ Therapeutics
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
TR1X
Neva First
United StatesSector
Biotech
InvestorNeva SGR
Entry
2022
Hold
4yr
Transcripta Bio
BlueYard Capital Fund II
United StatesSector
Biotech
InvestorBlueYard Capital
Entry
2020
Hold
6yr
Treefrog
Digital 3
FranceSector
Biotech
InvestorXAnge
Entry
2019
Hold
7yr
TRexBio
SV Life Sciences Fund VI
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2018
Hold
8yr
Triple Bio
Nucleus Capital II
NetherlandsSector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
Trishula Therapeutics
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
6yr
Triumvira Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Twig Bio
Project A Ventures IV
United KingdomSector
Biotech
InvestorProject A Ventures
Entry
2023
Hold
3yr
Tyris TX
Columbus Life Sciences Fund III
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2021
Hold
5yr
Valo Therapeutics
Indaco BIO
FinlandSector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2025
Hold
1yr
Van Heron Labs
FoodLabs Fund II
United StatesSector
Biotech
InvestorFoodLabs
Entry
2024
Hold
2yr
Vantage Biosciences
ALSA Ventures European Biotechnology Fund
UKSector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
VascVersa
Co-Fund NI
United KingdomSector
Biotech
InvestorClarendon Fund Managers
Entry
2021
Hold
5yr
Ventus Therapeutics
TVM Life Science Ventures
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
VEROVACCiNES
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Violet Therapeutics
Dementia Discovery Fund 2
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2023
Hold
3yr
Vivalyx
TechVision Fonds I
GermanySector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
VIVEbiotech
Inveready Biotech II
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2019
Hold
7yr
Vivoryon Therapeutics
bmp Aktiengesellschaft
GermanySector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Wugen
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2021
Hold
5yr
X-Therma
LIFTT
United StatesSector
Biotech
InvestorLIFTT
Entry
2024
Hold
2yr
Zedira
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Zentraxa
Elbow Beach Capital
UKSector
Biotech
InvestorElbow Beach Investments
Entry
2022
Hold
4yr
Abalos Therapeutics
coparion
GermanySector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4
Insempra
Possible Ventures Fund III
GermanySector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
4
NeoPhore
Neva First
United KingdomSector
Biotech
InvestorNeva SGR
Entry
2021
Hold
5yr
Owners
3
SenseUp
Simon Capital Evergreen
GermanySector
Biotech
InvestorSimon Capital
Entry
2025
Hold
1yr
Owners
3
Accure Therapeutics
Sabadell Asabys Health Innovation Investments
SpainSector
Biotech
InvestorAsabys Partners
Entry
2020
Hold
6yr
Owners
2
AdvanCell
Abingworth Bioventures 8
Australia
Sector
Biotech
InvestorAbingworth
Entry
2025
Hold
1yr
Owners
2
AmSilk
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2008
Hold
18yr
Owners
2
Atlas Bio
LEA Venturepartner (VC)
SwitzerlandSector
Biotech
InvestorLEA Partners
Entry
2024
Hold
2yr
Owners
2
Bluu Seafood
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2020
Hold
6yr
Owners
2
Cambrium
Redstone Ventures
GermanySector
Biotech
InvestorRedstone
Entry
2020
Hold
6yr
Owners
2
Captain T Cell GmbH
Technologiegründerfonds Sachsen
GermanySector
Biotech
InvestorCFH Management
Entry
2024
Hold
2yr
Owners
2
Formo
SevenVentures Media-for-Equity
GermanySector
Biotech
InvestorSevenVentures
Entry
2019
Hold
7yr
Owners
2
Graph Therapeutics
SquareOne III
AustriaSector
Biotech
InvestorSquareOne
Entry
2024
Hold
2yr
Owners
2
IAMA Therapeutics
Indaco BIO
ItalySector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2022
Hold
4yr
Owners
2
iDEL Therapeutics
Gruenderfonds Ruhr II
GermanySector
Biotech
InvestorGruenderfonds Ruhr
Entry
2025
Hold
1yr
Owners
2
Imperagen
IQ Capital Fund IV
UKSector
Biotech
InvestorIQ Capital Partners
Entry
2022
Hold
4yr
Owners
2
IMU Biosciences
IQ Capital Fund IV
UKSector
Biotech
InvestorIQ Capital Partners
Entry
2024
Hold
2yr
Owners
2